{"schema_version":"secwatch.filing_event.v1","accession":"0000877860-24-000012","form_type":"8-K","ticker":"NHI","cik":"0000877860","company_name":"NATIONAL HEALTH INVESTORS INC","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.111772+00:00","generated_at":"2026-06-05T23:40:24.895952+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NHI Q4 EPS $0.74 vs $0.04 YoY; issues 2024 NAREIT FFO guidance $4.31-$4.37","bullets":["Q4 diluted EPS $0.74 (vs $0.04); full-year EPS $3.13 (vs $1.48).","Q4 NAREIT FFO $1.09/diluted share (vs $0.74); FY FFO $4.39 (vs $3.55).","2024 guidance: NAREIT FFO $4.31-$4.37; Normalized FAD $191.3M-$194.1M.","Board approved $160M share repurchase plan for one year.","Net debt-to-adjusted EBITDA at 4.4x; liquidity includes $500M ATM program."],"urls":{"canonical":"https://secwatch.observer/filing/0000877860-24-000012","json":"https://secwatch.observer/filing/0000877860-24-000012.json","markdown":"https://secwatch.observer/filing/0000877860-24-000012.md","text":"https://secwatch.observer/filing/0000877860-24-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/877860/000087786024000012/0000877860-24-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/877860/000087786024000012/nhi-20240220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:40:24.895952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"938f62c71c4b47378af4c867a7033a9bef126d23","claim":"NATIONAL HEALTH INVESTORS INC reported the three and twelve months ended December 31, 2023 results: net income Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was, EPS Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was. Guidance initiated.","evidence_excerpt":"NHI Announces Fourth Quarter 2023 Results MURFREESBORO, Tenn. – (February 20, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786024000012/0000877860-24-000012-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and twelve months ended December 31, 2023"},{"label":"Net income","value":"Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was"},{"label":"EPS","value":"Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}